Cidara is pursuing an infectious disease-focused development strategy intended to transform standards of care and save lives.

Pipeline

  IND-Enabling
Phase 1
Phase 2
Phase 3

Candidemia and Invasive Candidiasis

Phase 3 Initiated

80%

Candida, PCP and Aspergillus in alloBMT


78%

Fungal Infections


26%
Research
IND-Enabling
Phase 1
Phase 2

Viral Infections – Influenza

Research

26%

GET IMPORTANT NEWS AND UPDATES BY EMAIL